REPORT ID 439

EMEA (Europe, Middle East and Africa) Immunohistochemistry Market Report 2017

Publish Date
01-Dec-17
Pages
108
Format
Electronic (PDF)

In this report, the EMEA Immunohistochemistry market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Immunohistochemistry for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Immunohistochemistry market competition by top manufacturers/players, with Immunohistochemistry sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Abcam plc
    Agilent Technologies, Inc.
    BioSB
    Cell Signaling Technology, Inc.
    Danaher
    F. Hoffmann-La Roche Ltd
    Merck Millipore
    PerkinElmer, Inc.
    Thermo Fisher Scientific Inc.

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Antibodies
    Equipment
    Reagents
    Kits

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Diagnostics
    Drug Testing

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Immunohistochemistry Market Report 2017
1 Immunohistochemistry Overview
    1.1 Product Overview and Scope of Immunohistochemistry
    1.2 Classification of Immunohistochemistry
        1.2.1 EMEA Immunohistochemistry Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Immunohistochemistry Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Antibodies
        1.2.4 Equipment
        1.2.5 Reagents
        1.2.6 Kits
    1.3 EMEA Immunohistochemistry Market by Application/End Users
        1.3.1 EMEA Immunohistochemistry Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Diagnostics
        1.3.3 Drug Testing
    1.4 EMEA Immunohistochemistry Market by Region
        1.4.1 EMEA Immunohistochemistry Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Immunohistochemistry (2012-2022)
        1.5.1 EMEA Immunohistochemistry Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Immunohistochemistry Revenue and Growth Rate (2012-2022)

2 EMEA Immunohistochemistry Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Immunohistochemistry Market Competition by Players/Manufacturers
        2.1.1 EMEA Immunohistochemistry Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Immunohistochemistry Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Immunohistochemistry Sale Price by Players (2012-2017)
    2.2 EMEA Immunohistochemistry (Volume and Value) by Type/Product Category
        2.2.1 EMEA Immunohistochemistry Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Immunohistochemistry Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Immunohistochemistry Sale Price by Type (2012-2017)
    2.3 EMEA Immunohistochemistry (Volume) by Application
    2.4 EMEA Immunohistochemistry (Volume and Value) by Region
        2.4.1 EMEA Immunohistochemistry Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Immunohistochemistry Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Immunohistochemistry Sales Price by Region (2012-2017)

3 Europe Immunohistochemistry (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Immunohistochemistry Sales and Value (2012-2017)
        3.1.1 Europe Immunohistochemistry Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Immunohistochemistry Revenue and Growth Rate (2012-2017)
    3.2 Europe Immunohistochemistry Sales and Market Share by Type
    3.3 Europe Immunohistochemistry Sales and Market Share by Application
    3.4 Europe Immunohistochemistry Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Immunohistochemistry Sales Volume by Countries (2012-2017)
        3.4.2 Europe Immunohistochemistry Revenue by Countries (2012-2017)
        3.4.3 Germany Immunohistochemistry Sales and Growth Rate (2012-2017)
        3.4.4 France Immunohistochemistry Sales and Growth Rate (2012-2017)
        3.4.5 UK Immunohistochemistry Sales and Growth Rate (2012-2017)
        3.4.6 Russia Immunohistochemistry Sales and Growth Rate (2012-2017)
        3.4.7 Italy Immunohistochemistry Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Immunohistochemistry Sales and Growth Rate (2012-2017)

4 Middle East Immunohistochemistry (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Immunohistochemistry Sales and Value (2012-2017)
        4.1.1 Middle East Immunohistochemistry Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Immunohistochemistry Revenue and Growth Rate (2012-2017)
    4.2 Middle East Immunohistochemistry Sales and Market Share by Type
    4.3 Middle East Immunohistochemistry Sales and Market Share by Application
    4.4 Middle East Immunohistochemistry Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Immunohistochemistry Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Immunohistochemistry Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Immunohistochemistry Sales and Growth Rate (2012-2017)
        4.4.4 Israel Immunohistochemistry Sales and Growth Rate (2012-2017)
        4.4.5 UAE Immunohistochemistry Sales and Growth Rate (2012-2017)
        4.4.6 Iran Immunohistochemistry Sales and Growth Rate (2012-2017)

5 Africa Immunohistochemistry (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Immunohistochemistry Sales and Value (2012-2017)
        5.1.1 Africa Immunohistochemistry Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Immunohistochemistry Revenue and Growth Rate (2012-2017)
    5.2 Africa Immunohistochemistry Sales and Market Share by Type
    5.3 Africa Immunohistochemistry Sales and Market Share by Application
    5.4 Africa Immunohistochemistry Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Immunohistochemistry Sales Volume by Countries (2012-2017)
        5.4.2 Africa Immunohistochemistry Revenue by Countries (2012-2017)
        5.4.3 South Africa Immunohistochemistry Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Immunohistochemistry Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Immunohistochemistry Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Immunohistochemistry Sales and Growth Rate (2012-2017)

6 EMEA Immunohistochemistry Manufacturers/Players Profiles and Sales Data
    6.1 Abcam plc
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Immunohistochemistry Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Abcam plc Immunohistochemistry Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Agilent Technologies, Inc.
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Immunohistochemistry Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Agilent Technologies, Inc. Immunohistochemistry Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 BioSB
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Immunohistochemistry Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 BioSB Immunohistochemistry Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Cell Signaling Technology, Inc.
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Immunohistochemistry Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Cell Signaling Technology, Inc. Immunohistochemistry Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Danaher
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Immunohistochemistry Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Danaher Immunohistochemistry Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 F. Hoffmann-La Roche Ltd
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Immunohistochemistry Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 F. Hoffmann-La Roche Ltd Immunohistochemistry Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Merck Millipore
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Immunohistochemistry Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Merck Millipore Immunohistochemistry Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 PerkinElmer, Inc.
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Immunohistochemistry Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 PerkinElmer, Inc. Immunohistochemistry Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Thermo Fisher Scientific Inc.
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Immunohistochemistry Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Thermo Fisher Scientific Inc. Immunohistochemistry Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview

7 Immunohistochemistry Manufacturing Cost Analysis
    7.1 Immunohistochemistry Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Immunohistochemistry

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Immunohistochemistry Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Immunohistochemistry Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Immunohistochemistry Market Forecast (2017-2022)
    11.1 EMEA Immunohistochemistry Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Immunohistochemistry Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Immunohistochemistry Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Immunohistochemistry Price and Trend Forecast (2017-2022)
    11.2 EMEA Immunohistochemistry Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Immunohistochemistry Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Immunohistochemistry Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Immunohistochemistry Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Immunohistochemistry Sales Forecast by Type (2017-2022)
    11.7 EMEA Immunohistochemistry Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer